President and CEO

Kehinde Joshua discovered :

Novel 1,4-O-linked Cellobiose

Novel Hexosaminidase inhibitors

Novel Tryptophanamide and 7-Aza tryptophanamide analogs organic compounds for Pharmaceutical Applications.

Structure-based Computational design of Novel Covalent Binder for treatment of sickle cell diseases.

He is a Passionate Scientific Researcher with vision for building something meaningful, our founder brings a blend of big-picture thinking and hands-on experience.
They set the tone for everything we do.

Executive Vice President

Focused, approachable, and driven by results, Our Vice President is all about building strong relationships. He helps connect people to the right solutions with clarity and care.

Head of Legal & Compliance

Our Head of Legal and Compliance at Kenneth Pharmaceutical company would act as a chief defender, corporate strategist, and ethical guardian of the business. She would work with Board of Directors, and bridges the gap between ambitious scientific innovation and rigid Federal Regulation.

Carolyn R Bertozzi is an American chemist and Nobel laureate who invented bioorthogonal chemistry, a method for running chemical reactions inside living things without harming normal cell processes.

Dr. Samuel Achilefu developed the technology behind the wearable Cancer Vision Goggles,

Eng. Abiodun Seyi Makinde design, test, and maintain the electronic hardware, that power modern medical devices, diagnostic tools in healthcare facilities

Apostle Joshua Selman is a Chemical Engineer with expertise in designing and managing large-scale industrial processes that turn raw materials into medicines.

Computational chemist known for his research in Structure-Based drug design molecular modelling and cheminformatics targeting infectious diseases.

Dr Monsurat Motunrayo Lawal specialized in computational biophysics drug design and Pharmaceutical chemistry.